4//SEC Filing
NANOGEN INC 4
Accession 0001181431-07-040540
CIK 0001030339operating
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 7:59 PM ET
Size
6.2 KB
Accession
0001181431-07-040540
Insider Transaction Report
Form 4
NANOGEN INCNGEN
LUDVIGSON DAVID
President & COO
Transactions
- Award
Performance Stock Option
2007-06-13+300,000→ 300,000 totalExercise: $1.39Exp: 2017-02-16→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]These performance-based options were approved by the board of directors of Issuer on February 16, 2007 ("Grant Date"), subject to shareholder approval of amendment of the stock option plan (the "Amended Plan") under which such options were granted. The option shares are awarded upon achievement of certain goals under the Issuer's bonus plan for the prior fiscal year at above-target levels. The options vest over a 4-year period, with 25% of option shares to vest upon completion of one year of service following the Grant Date, and the remaining option shares vest monthly over a 36-month period measured from the first anniversary of the Grant Date. The Issuer's shareholders approved the Amended Plan on June 13, 2007.
Documents
Issuer
NANOGEN INC
CIK 0001030339
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001030339
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 7:59 PM ET
- Size
- 6.2 KB